Showing results (421-430 of 772) with videos related to
Sort By:
Pageof 78
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Relation of tumor-cell ploidy to survival in children with medulloblastomaA J Gajjar, R L Heideman, E C Douglass, et al.Pediatric Neurosurgery|March 9, 2000
Malignant evolution of choroid plexus papillomaE Chow, J J Jenkins, P C Burger, et al.The Journal of Molecular Diagnostics : JMD|March 20, 2012
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNADaniëlle A M Heideman, Irene Lurkin, Marije Doeleman, et al.Personalized Medicine|May 15, 2018
Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapyJustine L Kuiper, Idris Bahce, Charlotte Voorhoeve, et al.Pediatric Neurosurgery|May 1, 1993
Response of pediatric low grade gliomas to chemotherapyA Gajjar, R L Heideman, E H Kovnar, et al.International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumorsThomas E Merchant, Ciara J Gould, Xiaoping Xiong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapyA Gajjar, R K Mulhern, R L Heideman, et al.Revista Brasileira De Enfermagem|July 16, 2020
Demands for psychosocial support from communities vulnerable to natural disastersGisele Cristina Manfrini Fernandes, Maria Lígia Dos Reis Bellaguarda, Ivonete Teresinha Schülter Buss Heideman, et al.Cancer Research|February 1, 1989
Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepaR L Heideman, D E Cole, F Balis, et al.The Journal of Pathology. Clinical Research|August 9, 2016
Somatic mutation in PIK3CA is a late event in cervical carcinogenesisWina Verlaat, Peter Jf Snijders, Marinda Ih van Moorsel, et al.Pageof 78